Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Neonatal NK cells target the mouse duct epithelium via Nkg2d and drive tissue-specific injury in experimental biliary atresia.

Shivakumar P, Sabla GE, Whitington P, Chougnet CA, Bezerra JA.

J Clin Invest. 2009 Aug;119(8):2281-90.

2.

Etiopathogenesis of biliary atresia.

Sokol RJ, Mack C.

Semin Liver Dis. 2001 Nov;21(4):517-24. Review.

PMID:
11745039
3.
4.

The next challenge in pediatric cholestasis: deciphering the pathogenesis of biliary atresia.

Bezerra JA.

J Pediatr Gastroenterol Nutr. 2006 Jul;43 Suppl 1:S23-9. Review.

PMID:
16819397
5.
6.

Murine cytomegalovirus regulation of NKG2D ligands.

Lenac T, Arapović J, Traven L, Krmpotić A, Jonjić S.

Med Microbiol Immunol. 2008 Jun;197(2):159-66. doi: 10.1007/s00430-008-0080-7. Epub 2008 Feb 8. Review.

PMID:
18259774
7.

Potential role of NKG2D and its ligands in organ transplantation: new target for immunointervention.

Suárez-Alvarez B, López-Vázquez A, Baltar JM, Ortega F, López-Larrea C.

Am J Transplant. 2009 Feb;9(2):251-7. doi: 10.1111/j.1600-6143.2008.02526.x. Review.

8.

Rotavirus and biliary atresia: can causation be proven?

Hertel PM, Estes MK.

Curr Opin Gastroenterol. 2012 Jan;28(1):10-7. doi: 10.1097/MOG.0b013e32834c7ae4. Review.

PMID:
22123643
9.

Biliary innate immunity in the pathogenesis of biliary diseases.

Harada K, Nakanuma Y.

Inflamm Allergy Drug Targets. 2010 Jun;9(2):83-90. Review.

PMID:
20402650
10.

NKG2D in NK and T cell-mediated immunity.

Ogasawara K, Lanier LL.

J Clin Immunol. 2005 Nov;25(6):534-40. Review.

PMID:
16380817
11.

Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response.

Chen Y, Wei H, Gao B, Hu Z, Zheng S, Tian Z.

J Viral Hepat. 2005 Jan;12(1):38-45. Review.

PMID:
15655046
12.

Viral inhibitors of NKG2D ligands: friends or foes of immune surveillance?

Jonjić S, Polić B, Krmpotić A.

Eur J Immunol. 2008 Nov;38(11):2952-6. doi: 10.1002/eji.200838823. Review.

13.

Biliary atresia.

Lefkowitch JH.

Mayo Clin Proc. 1998 Jan;73(1):90-5. Review.

PMID:
9443685
14.
15.

Biliary atresia.

Mieli-Vergani G, Vergani D.

Semin Immunopathol. 2009 Sep;31(3):371-81. doi: 10.1007/s00281-009-0171-6. Epub 2009 Jun 17. Review.

PMID:
19533128
16.

NKG2D ligands: key targets of the immune response.

González S, López-Soto A, Suarez-Alvarez B, López-Vázquez A, López-Larrea C.

Trends Immunol. 2008 Aug;29(8):397-403. doi: 10.1016/j.it.2008.04.007. Epub 2008 Jul 3. Review.

PMID:
18602338
17.

Potential etiologies of biliary atresia.

Bezerra JA.

Pediatr Transplant. 2005 Oct;9(5):646-51. Review.

PMID:
16176425
18.

Extrahepatic biliary atresia: a disease or a phenotype?

Perlmutter DH, Shepherd RW.

Hepatology. 2002 Jun;35(6):1297-304. Review. No abstract available.

PMID:
12029613
19.

NKG2D in innate and adaptive immunity.

Lanier LL.

Adv Exp Med Biol. 2005;560:51-6. Review. No abstract available.

PMID:
15934171
20.

Biliary atresia: a new immunological insight into etiopathogenesis.

Muraji T, Suskind DL, Irie N.

Expert Rev Gastroenterol Hepatol. 2009 Dec;3(6):599-606. doi: 10.1586/egh.09.61. Review.

PMID:
19929581
Items per page

Supplemental Content

Write to the Help Desk